IPP Bureau

Mankind Pharma acquires two brands from Dr Reddy’s
Mankind Pharma acquires two brands from Dr Reddy’s

By IPP Bureau - February 16, 2022

The entire integration and transition of the brands is expected to be completed by March 2022

Angus completes expansion of Louisiana site to include hydrochloride production
Angus completes expansion of Louisiana site to include hydrochloride production

By IPP Bureau - February 16, 2022

TRIS AMINO HCl is widely used as a diagnostic reagent and as a downstream processing buffer in the purification of commercial biopharmaceuticals

USFDA grants Breakthrough Designation for Datar’s early-stage prostate cancer detection blood test
USFDA grants Breakthrough Designation for Datar’s early-stage prostate cancer detection blood test

By IPP Bureau - February 15, 2022

Last year, the company's early-stage breast cancer detection test became the first such test to receive the Breakthrough Device Designation

Avion Pharmaceuticals announces USFDA approval of DHIVY
Avion Pharmaceuticals announces USFDA approval of DHIVY

By IPP Bureau - February 15, 2022

Parkinson's disease treatment is the first and only carbidopa/levodopa (CD/LD) tablet designed to be divided for precise dosing

Lynparza plus abiraterone effective in standard-of-care in 1st-line metastatic castration-resistant prostate cancer
Lynparza plus abiraterone effective in standard-of-care in 1st-line metastatic castration-resistant prostate cancer

By IPP Bureau - February 15, 2022

These results will be presented on 17 February at the 2022 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium

Launches and margin sustainability hold key for Glenmark: ICICI Direct
Launches and margin sustainability hold key for Glenmark: ICICI Direct

By IPP Bureau - February 15, 2022

Key takeaways of Q3FY22 quarter & conference call highlights

UFlex introduces a range of innovative and sustainable packaging solutions
UFlex introduces a range of innovative and sustainable packaging solutions

By IPP Bureau - February 15, 2022

Launches a host of innovative products & solutions across the entire flexible packaging value chain in October - December 2021

India’s tech-enabled vaccination drive applauded at India-Africa Health Summit
India’s tech-enabled vaccination drive applauded at India-Africa Health Summit

By IPP Bureau - February 15, 2022

It will open new frontier for south-to-south collaboration and innovation transfer

PyraMed telemedicine offers ‘Second Opinion Services’ for rural patients
PyraMed telemedicine offers ‘Second Opinion Services’ for rural patients

By IPP Bureau - February 15, 2022

The service has already been initiated in Maharashtra but being net-based it is easily available for patients all across the country

Crysta IVF onboards Dr. Neeta Jain as Head, Clinic Operations
Crysta IVF onboards Dr. Neeta Jain as Head, Clinic Operations

By IPP Bureau - February 15, 2022

She holds a Masters degree in Genetics along with a Ph.D. in Biochemistry

Visionflex chooses Vonage for its next-gen remote healthcare and diagnostic services
Visionflex chooses Vonage for its next-gen remote healthcare and diagnostic services

By IPP Bureau - February 14, 2022

Vonage Communications APIs allow developers to easily enhance and build intelligent, intuitive customer experiences directly into their existing applications and devices

Lilly's bebtelovimab receives EUA to treat mild-to-moderate Covid-19
Lilly's bebtelovimab receives EUA to treat mild-to-moderate Covid-19

By IPP Bureau - February 14, 2022

Bebtelovimab neutralizes Omicron as demonstrated by pseudo virus and authentic virus data

WHO prequalifies first monoclonal antibody - tocilizumab – to treat Covid-19
WHO prequalifies first monoclonal antibody - tocilizumab – to treat Covid-19

By IPP Bureau - February 14, 2022

The three prequalified products are manufactured by the originator company, Roche, but the listings should pave the way for more companies coming forward to seek WHO prequalification

Zydus gets 180 days of shared exclusivity for Roflumilast tablets
Zydus gets 180 days of shared exclusivity for Roflumilast tablets

By IPP Bureau - February 14, 2022

The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad

Clinical trials demonstrated safety of AstraZeneca and Sputnik Light vaccines combination
Clinical trials demonstrated safety of AstraZeneca and Sputnik Light vaccines combination

By IPP Bureau - February 14, 2022

Monitoring results demonstrated a good safety profile of the combination. No serious adverse events related to vaccination were registered

Latest Stories

Interviews

Packaging